phase readout
savePhase 2 primary completion: Dose-escalation of Regorafenib in Advanced Hepatocellular Carcinoma
November 15, 2026updated 9d ago
community read0 votes
Sponsor: Instituto do Cancer do Estado de São Paulo. Status: Active, not recruiting. Conditions: Liver Cancer, Hepatocellular Carcinoma. NCT05622136.
view source ↗Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that